Clinical Trial Update: Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE) [Phase 4]

View source ↗

Summary

Phase 4 trial update on etanercept and methotrexate in early arthritis aiming to induce remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: University of Leeds | Conditions: Rheumatoid Arthritis, Inflammatory Arthritis | Phase 4 | Status: COMPLETED